COTRIROL SUSPENSION

They are indicated for the following conditions:

  • Urogenital, particularly prostate-related issues.
  • Acute bronchopulmonary infections.
  • Middle ear infections.
  • Digestive infections, particularly typhoid fever.

 

COTRIROL Suspension

 

COMPOSITION

Each 5ml contain :

Sulfamethoxazole : ………………………………………………. 200 mg

Trimethoprim : ……………………………………………………….40 mg

Excipients : q.s …………………………………………………………..5ml

THERPEUTIC PROPERTIES

This medication is a combination of two antibiotics: sulfamethoxazole, from the sulfonamide class, and trimethoprim, from the diaminopyrimidine class.

INDICATIONS

They are indicated for the following conditions:

  • Urogenital, particularly prostate-related issues.
  • Acute bronchopulmonary infections.
  • Middle ear infections.
  • Digestive infections, particularly typhoid fever.

CONTRAINDICATIONS

This medication should not be used in the following cases:

  • A history of intolerance to any of the components (particularly sulfonamides).
  • Premature infants or newborns.

IN CASE OF DOUBT, IT IS NECESSARY TO ASK

FOR THE ADVICE OF YOUR DOCTOR OR PHARMACIST.

WARNING AND PRECAUTION

Hematological monitoring is recommended for prolonged treatment.

SIDE EFFECTS

  • Digestive disorders: nausea, stomach pain.
  • Skin manifestations: rash, urticaria. A few cases of epidermal necrolysis have been reported.
  • Cases of renal function impairment have been reported

DOSAGE AND METHOD OF ADMINISTRATION

Suspension for infants and children (pediatric)

  • From 6 weeks to 5 months: ½ teaspoon in the morning and evening.
  • From 6 months to 5 years (body weight less than 20 kg): 1 teaspoon in the morning and evening.
  • From 6 to 12 years (body weight greater than 20 kg): 2 teaspoons in the morning and evening.

STORAGE

  • Store below 30oC, avoid light and humidity
  • Keep out of reach and sight of children.
  • Do not use after expiry date.

Reviews

There are no reviews yet.

Be the first to review “COTRIROL SUSPENSION”

Your email address will not be published. Required fields are marked *